From December 31, 2022 to March 13, 2023, the company has repurchased 2,921,200 shares, representing 0.26% for CNY 100.97 million. With this, the company has completed the repurchase of 3,581,600 shares, representing 0.32% for CNY 120.97 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.2 CNY | -0.83% | -2.65% | -25.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.60% | 3.12B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.